Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prevacid Share Gains Show Impact Of Prior Authorization – Florida Report

Executive Summary

TAP's Prevacid is one of the big market-share winners under Florida's Medicaid supplemental rebate program, according to an analysis prepared for the state legislature

You may also be interested in...



Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow

Pfizer expects to see a "significant" increase in prescription utilization by seniors once Medicare drug coverage is enacted, CEO Henry McKinnell told securities analysts in New York City June 17

Pfizer Medicare Message: “Safeguards” Critical, Rx Growth Will Follow

Pfizer expects to see a "significant" increase in prescription utilization by seniors once Medicare drug coverage is enacted, CEO Henry McKinnell told securities analysts in New York City June 17

Florida Disease Management Report: Programs Save 11%; Rebates Save More

Industry-sponsored disease management services have saved the Florida Medicaid program approximately 11%, according to an analysis prepared for the state legislature

Related Content

UsernamePublicRestriction

Register

ID1125791

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel